Addus HomeCare Corporation (ADUS)
USD 105.0
(1.04%)
USD 105.0
(1.04%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 339.87 Million USD | 9.61% |
| 2022 | 299.73 Million USD | 11.08% |
| 2021 | 269.84 Million USD | 19.28% |
| 2020 | 226.23 Million USD | 26.22% |
| 2019 | 179.23 Million USD | 29.62% |
| 2018 | 138.27 Million USD | 19.62% |
| 2017 | 115.59 Million USD | 8.96% |
| 2016 | 106.09 Million USD | 16.18% |
| 2015 | 91.32 Million USD | 9.06% |
| 2014 | 83.73 Million USD | 23.61% |
| 2013 | 67.73 Million USD | 5.76% |
| 2012 | 64.05 Million USD | -21.69% |
| 2011 | 81.79 Million USD | 2.4% |
| 2010 | 79.87 Million USD | 4.26% |
| 2009 | 76.61 Million USD | 10.95% |
| 2008 | 69.05 Million USD | 24.87% |
| 2007 | 55.29 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 95.6 Million USD | 2.73% |
| 2024 Q1 | 88.17 Million USD | -2.28% |
| 2024 Q2 | 89.75 Million USD | 1.79% |
| 2023 Q3 | 86.73 Million USD | 5.36% |
| 2023 Q2 | 82.31 Million USD | 4.98% |
| 2023 Q4 | 90.23 Million USD | 4.04% |
| 2023 Q1 | 78.41 Million USD | -0.45% |
| 2023 FY | 328.55 Million USD | 9.61% |
| 2022 Q4 | 78.76 Million USD | 4.77% |
| 2022 Q2 | 75.59 Million USD | 7.71% |
| 2022 FY | 299.73 Million USD | 11.08% |
| 2022 Q1 | 70.18 Million USD | -3.58% |
| 2022 Q3 | 75.18 Million USD | -0.55% |
| 2021 Q2 | 68.81 Million USD | 12.44% |
| 2021 Q1 | 61.19 Million USD | 3.54% |
| 2021 FY | 269.84 Million USD | 19.28% |
| 2021 Q3 | 67.04 Million USD | -2.56% |
| 2021 Q4 | 72.79 Million USD | 8.57% |
| 2020 Q4 | 59.1 Million USD | 4.98% |
| 2020 FY | 226.23 Million USD | 26.22% |
| 2020 Q3 | 56.3 Million USD | 2.37% |
| 2020 Q1 | 55.83 Million USD | 1.14% |
| 2020 Q2 | 54.99 Million USD | -1.5% |
| 2019 Q4 | 55.2 Million USD | 20.05% |
| 2019 Q2 | 40.47 Million USD | 7.71% |
| 2019 FY | 179.23 Million USD | 29.62% |
| 2019 Q1 | 37.57 Million USD | -0.98% |
| 2019 Q3 | 45.98 Million USD | 13.63% |
| 2018 Q1 | 27.9 Million USD | -9.15% |
| 2018 Q4 | 37.94 Million USD | 3.38% |
| 2018 FY | 138.27 Million USD | 19.62% |
| 2018 Q3 | 36.7 Million USD | 2.75% |
| 2018 Q2 | 35.72 Million USD | 28.01% |
| 2017 Q1 | 27.31 Million USD | -4.67% |
| 2017 Q4 | 30.71 Million USD | 5.72% |
| 2017 Q3 | 29.05 Million USD | 1.9% |
| 2017 FY | 115.59 Million USD | 8.96% |
| 2017 Q2 | 28.51 Million USD | 4.37% |
| 2016 FY | 106.09 Million USD | 16.18% |
| 2016 Q3 | 27.42 Million USD | 6.73% |
| 2016 Q2 | 25.69 Million USD | 5.66% |
| 2016 Q1 | 24.31 Million USD | 9.58% |
| 2016 Q4 | 28.65 Million USD | 4.5% |
| 2015 Q3 | 23.52 Million USD | -0.68% |
| 2015 FY | 91.32 Million USD | 9.06% |
| 2015 Q4 | 22.19 Million USD | -5.65% |
| 2015 Q2 | 23.68 Million USD | 8.01% |
| 2015 Q1 | 21.92 Million USD | -3.18% |
| 2014 Q1 | 18.66 Million USD | 3.13% |
| 2014 Q2 | 35.55 Million USD | 90.48% |
| 2014 Q3 | 21.84 Million USD | -38.58% |
| 2014 Q4 | 22.64 Million USD | 3.7% |
| 2014 FY | 83.73 Million USD | 23.61% |
| 2013 Q2 | 16.61 Million USD | 5.16% |
| 2013 Q3 | 17.22 Million USD | 3.69% |
| 2013 Q4 | 18.1 Million USD | 5.09% |
| 2013 FY | 67.73 Million USD | 5.76% |
| 2013 Q1 | 15.79 Million USD | -9.92% |
| 2012 Q2 | 20.41 Million USD | 9.54% |
| 2012 FY | 64.05 Million USD | -21.69% |
| 2012 Q4 | 17.53 Million USD | -13.69% |
| 2012 Q1 | 18.64 Million USD | -13.78% |
| 2012 Q3 | 20.31 Million USD | -0.49% |
| 2011 FY | 81.79 Million USD | 2.4% |
| 2011 Q1 | 19.05 Million USD | -10.08% |
| 2011 Q2 | 20.11 Million USD | 5.54% |
| 2011 Q3 | 21.01 Million USD | 4.48% |
| 2011 Q4 | 21.62 Million USD | 2.9% |
| 2010 Q2 | 19.73 Million USD | 4.87% |
| 2010 Q1 | 18.82 Million USD | -3.94% |
| 2010 Q4 | 21.19 Million USD | 5.26% |
| 2010 Q3 | 20.13 Million USD | 2.01% |
| 2010 FY | 79.87 Million USD | 4.26% |
| 2009 Q2 | 19.22 Million USD | 6.0% |
| 2009 Q3 | 19.65 Million USD | 2.23% |
| 2009 FY | 76.61 Million USD | 10.95% |
| 2009 Q4 | 19.59 Million USD | -0.32% |
| 2009 Q1 | 18.13 Million USD | -4.81% |
| 2008 Q4 | 19.05 Million USD | 6.66% |
| 2008 FY | 69.05 Million USD | 24.87% |
| 2008 Q3 | 17.86 Million USD | 0.0% |
| 2007 FY | 55.29 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 682.6 Million USD | 50.209% |
| AirSculpt Technologies, Inc. | 121.9 Million USD | -178.804% |
| Amedisys, Inc. | 457.07 Million USD | 25.641% |
| Astrana Health, Inc. | 214.95 Million USD | -58.113% |
| Aveanna Healthcare Holdings Inc. | 595.43 Million USD | 42.919% |
| IMAC Holdings, Inc. | 3.84 Million USD | -8731.118% |
| biote Corp. | 127.48 Million USD | -166.605% |
| Cryo-Cell International, Inc. | 22.9 Million USD | -1384.085% |
| Cross Country Healthcare, Inc. | 432.06 Million USD | 21.336% |
| COMPASS Pathways plc | -242.93 Thousand USD | 140002.362% |
| DocGo Inc. | 178.95 Million USD | -89.927% |
| The Ensign Group, Inc. | 590.75 Million USD | 42.468% |
| Healthcare Services Group, Inc. | 251.45 Million USD | -35.166% |
| InnovAge Holding Corp. | 132.06 Million USD | -157.357% |
| The Joint Corp. | 107.14 Million USD | -217.197% |
| LifeStance Health Group, Inc. | 302.09 Million USD | -12.506% |
| Mobile-health Network Solutions Class A Ordinary Shares | -1.07 Million USD | 31815.353% |
| ModivCare Inc. | 446.95 Million USD | 23.957% |
| NewGenIvf Group Limited | 1.68 Million USD | -20109.242% |
| Option Care Health, Inc. | 981.22 Million USD | 65.362% |
| P3 Health Partners Inc. | 31.63 Million USD | -974.367% |
| P3 Health Partners Inc. | 31.63 Million USD | -974.367% |
| The Pennant Group, Inc. | 61.9 Million USD | -449.019% |
| Surgery Partners, Inc. | 529.4 Million USD | 35.8% |
| Syra Health Corp. Class A Common Stock | 1.41 Million USD | -23972.243% |
| Talkspace, Inc. | 74.38 Million USD | -356.945% |
| Talkspace, Inc. | 74.38 Million USD | -356.945% |
| The Oncology Institute, Inc. | 59.57 Million USD | -470.52% |
| The Oncology Institute, Inc. | 59.57 Million USD | -470.52% |